Biosynthesis of Zinc Oxide Nanoparticles Using Seaweed: Exploring Their Therapeutic Potentials

Abstract

This study aimed to biosynthesize zinc oxide nanoparticles (ZnO-NPs) using extracts from various seaweeds, including Ulva lactuca, Ulva intestinalis (Chlorophyta), and Sargassum muticum (Phaeophyceae). The biosynthesized ZnO-NPs were characterized using UV spectroscopy, Fourier transform infrared spectroscopy, X-ray diffraction, transmission electron microscopy, and zeta potential analysis. Their antimicrobial activity was assessed using the disk diffusion method, revealing significant efficacy against two bacterial species (Klebsiella pneumoniae and Escherichia coli) and two fungal species (Candida albicans and Aspergillus niger). Additionally, the antioxidant potential of the ZnO-NPs was evaluated based on the total antioxidant capacity, ferric reducing antioxidant power, and DPPH (2,2-diphenyl-1-picrylhydrazyl) radical scavenging assays. The antioxidant activity of the ZnO-NPs was confirmed using the three antioxidant assays. The ZnO-NPs of U. lactuca recorded the highest antioxidant activity. The cytotoxicity of the ZnO-NPs was tested on different cell lines using the MTT assay. The ZnO-NPs of U. lactuca showed very weak cytotoxic effects on WI 38 (84.98 ± 4.6 µg/mL) and 23, and this result confirmed its safety on normal cells. The ZnO-NPs of U. lactuca showed moderate cytotoxic effects on the HepG-2 (46.66 ± 2.8 µg/mL) and MCF-7 (30.60 ± 2.1 µg/mL) cell lines. In an in vivo study, the ZnO-NPs of U. lactuca showed a decrease in tumor volume, weight, and serum malondialdehyde in experimental mice, while the total antioxidant capacity of the serum was increased. Histopathological changes in ZnO-NPs indicated a reduction in tumor size, a lower number of mitosis divisions, and a rise in apoptosis correlated with the ZnO-NPs of the U. lactuca-treated groups. In conclusion, biosynthesized ZnO-NPs from seaweed showed potent antimicrobial, antioxidant, and antitumor activities, which can be used in the pharmaceutical industry.